Show Summary Details
Page of

Economic analysis of interventions against infectious diseases 

Economic analysis of interventions against infectious diseases
Chapter:
Economic analysis of interventions against infectious diseases
Author(s):

Mark Jit

and Peter White

DOI:
10.1093/med/9780198719830.003.0017
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 February 2020

Health-care resources are scarce, and not all possible needs can be met, so some sort of priority setting (or rationing) is inevitable. The aim of health economic evaluation is not necessarily to save money, but to make the best use of scarce resources by informing decisions on resource allocation using explicit, evidence-based, and needs-based criteria. Economic evaluation compares the costs and consequences of options to find those that achieve the best outcomes based on specified criteria. It is often necessary to compare across diseases using generic measures of health that consider morbidity and mortality, e.g. quality-adjusted life-years (QALYs) and disability-adjusted life-years (DALYs). With infectious diseases, population-level effects of interventions can be both beneficial and detrimental. Effects (on rates of onward transmission) can outlive individual patients. Transmission-dynamic models thus are required, so economic evaluation needs to be performed by analysts familiar with both health economics and the special epidemiological features of infectious diseases.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.